For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260527:nRSa7047Fa&default-theme=true
RNS Number : 7047F Fevertree Drinks PLC 27 May 2026
27(th) May 2026
Fevertree Drinks plc
("Fever-Tree" or the "Company")
Transaction in Own Shares
Fevertree Drinks plc ("Fever-Tree" or the "Company") announces today it has,
in accordance with the authority granted by shareholders at its 2025 Annual
General Meeting held on 5(th) June, purchased the following number of ordinary
shares of £0.0025 each in the Company (the "Ordinary Shares") through the
Company's broker, Investec Bank plc ("Investec") in the period from 18(th) May
to 22(nd) May 2026.
Date Venue Volume-weighted average price (p) Aggregated volume Lowest price per share (p) Highest price per share (p)
18 May 2026 XLON 774.0739 44,601 760.5000 780.0000
19 May 2026 XLON 769.9506 25,142 761.5000 779.0000
19 May 2026 AIMX 777.2500 20,000 777.2500 777.2500
20 May 2026 XLON 769.5753 45,662 759.0000 785.5000
21 May 2026 XLON 773.8406 33,793 762.5000 780.0000
22 May 2026 XLON 781.5824 32,424 778.0000 788.5000
The Company intends to cancel the purchased shares.
Schedule of Purchases - Individual Transactions
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation) (which forms part of domestic UK law by virtue of the
European Union (Withdrawal) Act 2018, as amended), a full breakdown of the
individual trades made by Investec on behalf of the Company as part of the
share buyback programme is attached to this announcement.
http://www.rns-pdf.londonstockexchange.com/rns/7047F_1-2026-5-26.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/7047F_1-2026-5-26.pdf)
This announcement does not constitute, or form part of, an offer or any
solicitation of an offer for securities in any jurisdiction.
For further information please contact:
Investor queries
Steve Nightingale, Director of Investor Relations I
steve.nightingale@fever-tree.com I +44 (0)7951 849564
Media queries
Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I
+44 (0)770 332 9024
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSVQLBLQELZBBD
Copyright 2019 Regulatory News Service, all rights reserved